Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes
Nrg1β is critically involved in cardiac development and also maintains function of the adult heart. Studies conducted in animal models showed that it improves cardiac performance under a range of pathological conditions, which led to its introduction in clinical trials to treat heart failure. Recent...
Gespeichert in:
Veröffentlicht in: | American journal of physiology: endocrinology and metabolism 2016-05, Vol.310 (9), p.E782-E794 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | E794 |
---|---|
container_issue | 9 |
container_start_page | E782 |
container_title | American journal of physiology: endocrinology and metabolism |
container_volume | 310 |
creator | Pentassuglia, Laura Heim, Philippe Lebboukh, Sonia Morandi, Christian Xu, Lifen Brink, Marijke |
description | Nrg1β is critically involved in cardiac development and also maintains function of the adult heart. Studies conducted in animal models showed that it improves cardiac performance under a range of pathological conditions, which led to its introduction in clinical trials to treat heart failure. Recent work also implicated Nrg1β in the regenerative potential of neonatal and adult hearts. The molecular mechanisms whereby Nrg1β acts in cardiac cells are still poorly understood. In the present study, we analyzed the effects of Nrg1β on glucose uptake in neonatal rat ventricular myocytes and investigated to what extent mTOR/Akt signaling pathways are implicated. We show that Nrg1β enhances glucose uptake in cardiomyocytes as efficiently as IGF-I and insulin. Nrg1β causes phosphorylation of ErbB2 and ErbB4 and rapidly induces the phosphorylation of FAK (Tyr(861)), Akt (Thr(308) and Ser(473)), and its effector AS160 (Thr(642)). Knockdown of ErbB2 or ErbB4 reduces Akt phosphorylation and blocks the glucose uptake. The Akt inhibitor VIII and the PI3K inhibitors LY-294002 and Byl-719 abolish Nrg1β-induced phosphorylation and glucose uptake. Finally, specific mTORC2 inactivation after knockdown of rictor blocks the Nrg1β-induced increases in Akt-p-Ser(473) but does not modify AS160-p-Thr(642) or the glucose uptake responses to Nrg1β. In conclusion, our study demonstrates that Nrg1β enhances glucose uptake in cardiomyocytes via ErbB2/ErbB4 heterodimers, PI3Kα, and Akt. Furthermore, although Nrg1β activates mTORC2, the resulting Akt-Ser(473) phosphorylation is not essential for glucose uptake induction. These new insights into pathways whereby Nrg1β regulates glucose uptake in cardiomyocytes may contribute to the understanding of its regenerative capacity and protective function in heart failure. |
doi_str_mv | 10.1152/ajpendo.00259.2015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1811893121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1811893121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-f0c65ae3862a113f16243eb3944ed6c0104cccc33b8724df000f3867cd7d7e7d3</originalsourceid><addsrcrecordid>eNqFkE1OwzAQRi0EoqVwARbISzZpPXYcJ8uq4qeiAoRgHbm2U6VN4mAnSL0WB-FMuLSwZTazmPeNPj2ELoGMATidyHVrGm3HhFCejSkBfoSG4UAj4JwfoyGBjEWQxtkAnXm_JoQIHtNTNKBJJrIADtHLo-mdWfVV2UTw9YlbZ2vbGY9XVa-sN7hvO7kx-KOU-HnOHibTTYfLBjfGNrKTFXayw0o6Xdp6a9U2RM_RSSErby4Oe4Tebm9eZ_fR4uluPpsuIsVS0kUFUQmXhqUJlQCsgITGzCxZFsdGJ4oAiVUYxpapoLEuQvsiwEJpoYURmo3Q9f5v6PzeG9_ldemVqSoZyvU-hxQgzRhQ-B8VqSAZ4VwElO5R5az3zhR568paum0OJN9pzw_a8x_t-U57CF0d_vfL2ui_yK9n9g3re3-2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1787090557</pqid></control><display><type>article</type><title>Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Pentassuglia, Laura ; Heim, Philippe ; Lebboukh, Sonia ; Morandi, Christian ; Xu, Lifen ; Brink, Marijke</creator><creatorcontrib>Pentassuglia, Laura ; Heim, Philippe ; Lebboukh, Sonia ; Morandi, Christian ; Xu, Lifen ; Brink, Marijke</creatorcontrib><description>Nrg1β is critically involved in cardiac development and also maintains function of the adult heart. Studies conducted in animal models showed that it improves cardiac performance under a range of pathological conditions, which led to its introduction in clinical trials to treat heart failure. Recent work also implicated Nrg1β in the regenerative potential of neonatal and adult hearts. The molecular mechanisms whereby Nrg1β acts in cardiac cells are still poorly understood. In the present study, we analyzed the effects of Nrg1β on glucose uptake in neonatal rat ventricular myocytes and investigated to what extent mTOR/Akt signaling pathways are implicated. We show that Nrg1β enhances glucose uptake in cardiomyocytes as efficiently as IGF-I and insulin. Nrg1β causes phosphorylation of ErbB2 and ErbB4 and rapidly induces the phosphorylation of FAK (Tyr(861)), Akt (Thr(308) and Ser(473)), and its effector AS160 (Thr(642)). Knockdown of ErbB2 or ErbB4 reduces Akt phosphorylation and blocks the glucose uptake. The Akt inhibitor VIII and the PI3K inhibitors LY-294002 and Byl-719 abolish Nrg1β-induced phosphorylation and glucose uptake. Finally, specific mTORC2 inactivation after knockdown of rictor blocks the Nrg1β-induced increases in Akt-p-Ser(473) but does not modify AS160-p-Thr(642) or the glucose uptake responses to Nrg1β. In conclusion, our study demonstrates that Nrg1β enhances glucose uptake in cardiomyocytes via ErbB2/ErbB4 heterodimers, PI3Kα, and Akt. Furthermore, although Nrg1β activates mTORC2, the resulting Akt-Ser(473) phosphorylation is not essential for glucose uptake induction. These new insights into pathways whereby Nrg1β regulates glucose uptake in cardiomyocytes may contribute to the understanding of its regenerative capacity and protective function in heart failure.</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00259.2015</identifier><identifier>PMID: 26979522</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Animals, Newborn ; Blotting, Western ; Gene Knockdown Techniques ; Glucose - metabolism ; Heart Ventricles - cytology ; Hypoglycemic Agents - pharmacology ; Immunoprecipitation ; Insulin - pharmacology ; Insulin-Like Growth Factor I - pharmacology ; Mechanistic Target of Rapamycin Complex 2 ; Mice ; Mice, Inbred C57BL ; Multiprotein Complexes - metabolism ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Neuregulin-1 - pharmacology ; Phosphatidylinositol 3-Kinases - drug effects ; Phosphatidylinositol 3-Kinases - metabolism ; Phosphorylation - drug effects ; Protein Biosynthesis - drug effects ; Proto-Oncogene Proteins c-akt - drug effects ; Proto-Oncogene Proteins c-akt - metabolism ; Rats ; Receptor, ErbB-2 - drug effects ; Receptor, ErbB-2 - genetics ; Receptor, ErbB-2 - metabolism ; Receptor, ErbB-4 - drug effects ; Receptor, ErbB-4 - genetics ; Receptor, ErbB-4 - metabolism ; RNA, Small Interfering ; TOR Serine-Threonine Kinases - metabolism</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2016-05, Vol.310 (9), p.E782-E794</ispartof><rights>Copyright © 2016 the American Physiological Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-f0c65ae3862a113f16243eb3944ed6c0104cccc33b8724df000f3867cd7d7e7d3</citedby><cites>FETCH-LOGICAL-c380t-f0c65ae3862a113f16243eb3944ed6c0104cccc33b8724df000f3867cd7d7e7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26979522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pentassuglia, Laura</creatorcontrib><creatorcontrib>Heim, Philippe</creatorcontrib><creatorcontrib>Lebboukh, Sonia</creatorcontrib><creatorcontrib>Morandi, Christian</creatorcontrib><creatorcontrib>Xu, Lifen</creatorcontrib><creatorcontrib>Brink, Marijke</creatorcontrib><title>Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>Nrg1β is critically involved in cardiac development and also maintains function of the adult heart. Studies conducted in animal models showed that it improves cardiac performance under a range of pathological conditions, which led to its introduction in clinical trials to treat heart failure. Recent work also implicated Nrg1β in the regenerative potential of neonatal and adult hearts. The molecular mechanisms whereby Nrg1β acts in cardiac cells are still poorly understood. In the present study, we analyzed the effects of Nrg1β on glucose uptake in neonatal rat ventricular myocytes and investigated to what extent mTOR/Akt signaling pathways are implicated. We show that Nrg1β enhances glucose uptake in cardiomyocytes as efficiently as IGF-I and insulin. Nrg1β causes phosphorylation of ErbB2 and ErbB4 and rapidly induces the phosphorylation of FAK (Tyr(861)), Akt (Thr(308) and Ser(473)), and its effector AS160 (Thr(642)). Knockdown of ErbB2 or ErbB4 reduces Akt phosphorylation and blocks the glucose uptake. The Akt inhibitor VIII and the PI3K inhibitors LY-294002 and Byl-719 abolish Nrg1β-induced phosphorylation and glucose uptake. Finally, specific mTORC2 inactivation after knockdown of rictor blocks the Nrg1β-induced increases in Akt-p-Ser(473) but does not modify AS160-p-Thr(642) or the glucose uptake responses to Nrg1β. In conclusion, our study demonstrates that Nrg1β enhances glucose uptake in cardiomyocytes via ErbB2/ErbB4 heterodimers, PI3Kα, and Akt. Furthermore, although Nrg1β activates mTORC2, the resulting Akt-Ser(473) phosphorylation is not essential for glucose uptake induction. These new insights into pathways whereby Nrg1β regulates glucose uptake in cardiomyocytes may contribute to the understanding of its regenerative capacity and protective function in heart failure.</description><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Blotting, Western</subject><subject>Gene Knockdown Techniques</subject><subject>Glucose - metabolism</subject><subject>Heart Ventricles - cytology</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Immunoprecipitation</subject><subject>Insulin - pharmacology</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Mechanistic Target of Rapamycin Complex 2</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Multiprotein Complexes - metabolism</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Neuregulin-1 - pharmacology</subject><subject>Phosphatidylinositol 3-Kinases - drug effects</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Phosphorylation - drug effects</subject><subject>Protein Biosynthesis - drug effects</subject><subject>Proto-Oncogene Proteins c-akt - drug effects</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Rats</subject><subject>Receptor, ErbB-2 - drug effects</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Receptor, ErbB-2 - metabolism</subject><subject>Receptor, ErbB-4 - drug effects</subject><subject>Receptor, ErbB-4 - genetics</subject><subject>Receptor, ErbB-4 - metabolism</subject><subject>RNA, Small Interfering</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1OwzAQRi0EoqVwARbISzZpPXYcJ8uq4qeiAoRgHbm2U6VN4mAnSL0WB-FMuLSwZTazmPeNPj2ELoGMATidyHVrGm3HhFCejSkBfoSG4UAj4JwfoyGBjEWQxtkAnXm_JoQIHtNTNKBJJrIADtHLo-mdWfVV2UTw9YlbZ2vbGY9XVa-sN7hvO7kx-KOU-HnOHibTTYfLBjfGNrKTFXayw0o6Xdp6a9U2RM_RSSErby4Oe4Tebm9eZ_fR4uluPpsuIsVS0kUFUQmXhqUJlQCsgITGzCxZFsdGJ4oAiVUYxpapoLEuQvsiwEJpoYURmo3Q9f5v6PzeG9_ldemVqSoZyvU-hxQgzRhQ-B8VqSAZ4VwElO5R5az3zhR568paum0OJN9pzw_a8x_t-U57CF0d_vfL2ui_yK9n9g3re3-2</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Pentassuglia, Laura</creator><creator>Heim, Philippe</creator><creator>Lebboukh, Sonia</creator><creator>Morandi, Christian</creator><creator>Xu, Lifen</creator><creator>Brink, Marijke</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TS</scope></search><sort><creationdate>20160501</creationdate><title>Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes</title><author>Pentassuglia, Laura ; Heim, Philippe ; Lebboukh, Sonia ; Morandi, Christian ; Xu, Lifen ; Brink, Marijke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-f0c65ae3862a113f16243eb3944ed6c0104cccc33b8724df000f3867cd7d7e7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Blotting, Western</topic><topic>Gene Knockdown Techniques</topic><topic>Glucose - metabolism</topic><topic>Heart Ventricles - cytology</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Immunoprecipitation</topic><topic>Insulin - pharmacology</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Mechanistic Target of Rapamycin Complex 2</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Multiprotein Complexes - metabolism</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Neuregulin-1 - pharmacology</topic><topic>Phosphatidylinositol 3-Kinases - drug effects</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Phosphorylation - drug effects</topic><topic>Protein Biosynthesis - drug effects</topic><topic>Proto-Oncogene Proteins c-akt - drug effects</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Rats</topic><topic>Receptor, ErbB-2 - drug effects</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Receptor, ErbB-2 - metabolism</topic><topic>Receptor, ErbB-4 - drug effects</topic><topic>Receptor, ErbB-4 - genetics</topic><topic>Receptor, ErbB-4 - metabolism</topic><topic>RNA, Small Interfering</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pentassuglia, Laura</creatorcontrib><creatorcontrib>Heim, Philippe</creatorcontrib><creatorcontrib>Lebboukh, Sonia</creatorcontrib><creatorcontrib>Morandi, Christian</creatorcontrib><creatorcontrib>Xu, Lifen</creatorcontrib><creatorcontrib>Brink, Marijke</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Physical Education Index</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pentassuglia, Laura</au><au>Heim, Philippe</au><au>Lebboukh, Sonia</au><au>Morandi, Christian</au><au>Xu, Lifen</au><au>Brink, Marijke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>310</volume><issue>9</issue><spage>E782</spage><epage>E794</epage><pages>E782-E794</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>Nrg1β is critically involved in cardiac development and also maintains function of the adult heart. Studies conducted in animal models showed that it improves cardiac performance under a range of pathological conditions, which led to its introduction in clinical trials to treat heart failure. Recent work also implicated Nrg1β in the regenerative potential of neonatal and adult hearts. The molecular mechanisms whereby Nrg1β acts in cardiac cells are still poorly understood. In the present study, we analyzed the effects of Nrg1β on glucose uptake in neonatal rat ventricular myocytes and investigated to what extent mTOR/Akt signaling pathways are implicated. We show that Nrg1β enhances glucose uptake in cardiomyocytes as efficiently as IGF-I and insulin. Nrg1β causes phosphorylation of ErbB2 and ErbB4 and rapidly induces the phosphorylation of FAK (Tyr(861)), Akt (Thr(308) and Ser(473)), and its effector AS160 (Thr(642)). Knockdown of ErbB2 or ErbB4 reduces Akt phosphorylation and blocks the glucose uptake. The Akt inhibitor VIII and the PI3K inhibitors LY-294002 and Byl-719 abolish Nrg1β-induced phosphorylation and glucose uptake. Finally, specific mTORC2 inactivation after knockdown of rictor blocks the Nrg1β-induced increases in Akt-p-Ser(473) but does not modify AS160-p-Thr(642) or the glucose uptake responses to Nrg1β. In conclusion, our study demonstrates that Nrg1β enhances glucose uptake in cardiomyocytes via ErbB2/ErbB4 heterodimers, PI3Kα, and Akt. Furthermore, although Nrg1β activates mTORC2, the resulting Akt-Ser(473) phosphorylation is not essential for glucose uptake induction. These new insights into pathways whereby Nrg1β regulates glucose uptake in cardiomyocytes may contribute to the understanding of its regenerative capacity and protective function in heart failure.</abstract><cop>United States</cop><pmid>26979522</pmid><doi>10.1152/ajpendo.00259.2015</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0193-1849 |
ispartof | American journal of physiology: endocrinology and metabolism, 2016-05, Vol.310 (9), p.E782-E794 |
issn | 0193-1849 1522-1555 |
language | eng |
recordid | cdi_proquest_miscellaneous_1811893121 |
source | MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Animals, Newborn Blotting, Western Gene Knockdown Techniques Glucose - metabolism Heart Ventricles - cytology Hypoglycemic Agents - pharmacology Immunoprecipitation Insulin - pharmacology Insulin-Like Growth Factor I - pharmacology Mechanistic Target of Rapamycin Complex 2 Mice Mice, Inbred C57BL Multiprotein Complexes - metabolism Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism Neuregulin-1 - pharmacology Phosphatidylinositol 3-Kinases - drug effects Phosphatidylinositol 3-Kinases - metabolism Phosphorylation - drug effects Protein Biosynthesis - drug effects Proto-Oncogene Proteins c-akt - drug effects Proto-Oncogene Proteins c-akt - metabolism Rats Receptor, ErbB-2 - drug effects Receptor, ErbB-2 - genetics Receptor, ErbB-2 - metabolism Receptor, ErbB-4 - drug effects Receptor, ErbB-4 - genetics Receptor, ErbB-4 - metabolism RNA, Small Interfering TOR Serine-Threonine Kinases - metabolism |
title | Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A48%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuregulin-1%CE%B2%20promotes%20glucose%20uptake%20via%20PI3K/Akt%20in%20neonatal%20rat%20cardiomyocytes&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Pentassuglia,%20Laura&rft.date=2016-05-01&rft.volume=310&rft.issue=9&rft.spage=E782&rft.epage=E794&rft.pages=E782-E794&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.00259.2015&rft_dat=%3Cproquest_cross%3E1811893121%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1787090557&rft_id=info:pmid/26979522&rfr_iscdi=true |